A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer

Launched by M.D. ANDERSON CANCER CENTER · May 23, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how a group-based writing program can help improve the quality of life for young adults who have survived cancer. Specifically, it focuses on individuals aged 15 to 39 who were diagnosed with stage II-IV cancer and have completed their active treatment within the last five years. The goal is to understand their experiences better and see if sharing their thoughts and feelings through writing in a supportive group can make a positive difference in their lives.

To participate, candidates must be between 18 and 39 years old at the time they join the study and should be able to communicate in English. Participants will not be able to join if they have certain types of skin cancer or major mental health issues, and they also need to have internet access. Those who take part can expect to engage in virtual writing sessions with others who have similar experiences, providing a space for connection and healing. Overall, this study aims to support young cancer survivors in navigating life after treatment.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Age 15-39 years at cancer diagnosis
• • Age 18-39 years at study entry
• • Within 5 years of diagnosis of stage II-IV cancer
• • Completed active treatment (participants receiving maintenance therapy remain eligible)
• • No evidence of disease
• • Can speak, read, and write in English.
• Exclusion criteria:
• • Nonmelanoma skin cancer
• • Major mental health disorder (e.g., schizophrenia or bipolar disorder \[determined from patient records or self-disclosure\])
• • No internet access.

Trial Officials